Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AMFPF OTCMKTS:BMXMF NYSE:LH NASDAQ:NTRA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMFPFAmplifon$23.85$23.23$19.00▼$31.88$5.38B0.5428 shsN/ABMXMFbioMerieux$142.45$137.75$96.54▼$143.47$16.86B0.743 shsN/ALHLabcorp$243.73-1.4%$253.65$205.98▼$265.72$20.40B0.82653,135 shs573,363 shsNTRANatera$138.90-3.1%$160.09$92.14▼$183.00$18.97B1.731.42 million shs1.38 million shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMFPFAmplifon0.00%0.00%0.00%+25.53%-31.86%BMXMFbioMerieux0.00%0.00%0.00%+8.12%+38.98%LHLabcorp-1.38%-2.21%-6.82%+12.19%+12.91%NTRANatera-3.12%-13.42%-18.76%-6.20%+25.85%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMFPFAmplifonN/AN/AN/AN/AN/AN/AN/AN/ABMXMFbioMerieuxN/AN/AN/AN/AN/AN/AN/AN/ALHLabcorp4.5607 of 5 stars3.32.02.54.22.02.51.3NTRANatera2.7765 of 5 stars3.51.00.00.03.52.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMFPFAmplifon 2.50Moderate BuyN/AN/ABMXMFbioMerieux 3.00BuyN/AN/ALHLabcorp 2.57Moderate Buy$276.0813.27% UpsideNTRANatera 3.00Buy$184.6332.92% UpsideCurrent Analyst Ratings BreakdownLatest AMFPF, LH, NTRA, and BMXMF Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/18/2025LHLabcorpUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$284.00 ➝ $282.007/10/2025LHLabcorpHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold7/10/2025LHLabcorpHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$260.007/9/2025LHLabcorpEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$260.00 ➝ $285.006/25/2025AMFPFAmplifonMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingCautious ➝ Cautious6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.006/11/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.005/15/2025NTRANateraPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$205.00 ➝ $210.005/13/2025AMFPFAmplifonMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight5/12/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$274.00 ➝ $290.00(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMFPFAmplifon$2.61B2.06$2.19 per share10.90$5.52 per share4.32BMXMFbioMerieux$4.31B3.91$4.48 per share31.79$38.50 per share3.70LHLabcorp$13.01B1.57$22.40 per share10.88$96.27 per share2.53NTRANatera$1.70B11.18N/AN/A$9.05 per share15.35Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMFPFAmplifon$157.31M$0.6835.07∞N/A5.90%13.68%3.97%7/29/2025 (Estimated)BMXMFbioMerieux$467.68MN/A0.00∞N/AN/AN/AN/A9/4/2025 (Estimated)LHLabcorp$746M$8.6528.1813.901.545.55%15.27%6.97%7/24/2025 (Estimated)NTRANatera-$190.43M-$1.47N/AN/AN/A-10.36%-18.29%-11.68%8/14/2025 (Estimated)Latest AMFPF, LH, NTRA, and BMXMF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025NTRANatera-$0.60N/AN/AN/AN/AN/A7/24/2025Q2 2025LHLabcorp$4.12N/AN/AN/A$3.49 billionN/A5/8/2025Q1 2025NTRANatera-$0.59-$0.50+$0.09-$0.50$446.68 million$501.83 million4/29/2025Q1 2025LHLabcorp$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMFPFAmplifonN/AN/AN/AN/AN/ABMXMFbioMerieuxN/AN/AN/AN/AN/ALHLabcorp$2.881.18%N/A33.29%N/ANTRANateraN/AN/AN/AN/AN/ALatest AMFPF, LH, NTRA, and BMXMF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/10/2025LHLabcorpquarterly$0.721.11%8/28/20259/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMFPFAmplifon0.830.620.54BMXMFbioMerieux0.082.201.29LHLabcorp0.681.841.60NTRANateraN/A3.873.74Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMFPFAmplifonN/ABMXMFbioMerieuxN/ALHLabcorp95.94%NTRANatera99.90%Insider OwnershipCompanyInsider OwnershipAMFPFAmplifonN/ABMXMFbioMerieuxN/ALHLabcorp0.84%NTRANatera7.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMFPFAmplifon15,070225.50 millionN/ANot OptionableBMXMFbioMerieux14,600118.36 millionN/ANot OptionableLHLabcorp70,00083.70 million83.00 millionOptionableNTRANatera4,434136.55 million126.17 millionOptionableAMFPF, LH, NTRA, and BMXMF HeadlinesRecent News About These CompaniesJennison Associates LLC Has $56.38 Million Stock Holdings in Natera, Inc. (NASDAQ:NTRA)July 19 at 7:31 AM | marketbeat.comVictory Capital Management Inc. Purchases 73,003 Shares of Natera, Inc. (NASDAQ:NTRA)July 19 at 6:12 AM | marketbeat.comEdgestream Partners L.P. Makes New Investment in Natera, Inc. (NASDAQ:NTRA)July 19 at 5:16 AM | marketbeat.comCwm LLC Acquires 3,077 Shares of Natera, Inc. (NASDAQ:NTRA)July 18 at 4:42 AM | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Given Average Rating of "Buy" by BrokeragesJuly 17 at 2:46 AM | marketbeat.comSeaBridge Investment Advisors LLC Increases Stake in Natera, Inc. (NASDAQ:NTRA)July 16 at 8:35 AM | marketbeat.comEnvestnet Asset Management Inc. Reduces Stock Position in Natera, Inc. (NASDAQ:NTRA)July 16 at 3:43 AM | marketbeat.comKornitzer Capital Management Inc. KS Sells 17,945 Shares of Natera, Inc. (NASDAQ:NTRA)July 15, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Has $331.55 Million Position in Natera, Inc. (NASDAQ:NTRA)July 15, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Position Boosted by Arizona State Retirement SystemJuly 15, 2025 | marketbeat.comCerity Partners LLC Buys 5,863 Shares of Natera, Inc. (NASDAQ:NTRA)July 15, 2025 | marketbeat.comNatera, Inc. (NTRA): A Bull Case TheoryJuly 14, 2025 | insidermonkey.comCenterBook Partners LP Makes New Investment in Natera, Inc. (NASDAQ:NTRA)July 14, 2025 | marketbeat.comXponance Inc. Has $3.19 Million Stock Holdings in Natera, Inc. (NASDAQ:NTRA)July 14, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Stock Holdings Lifted by Axxcess Wealth Management LLCJuly 13, 2025 | marketbeat.comPenserra Capital Management LLC Sells 16,224 Shares of Natera, Inc. (NASDAQ:NTRA)July 13, 2025 | marketbeat.comNisa Investment Advisors LLC Acquires 8,542 Shares of Natera, Inc. (NASDAQ:NTRA)July 12, 2025 | marketbeat.comUS judge rebukes law firm Quinn Emanuel, awards $3 million sanction in Guardant caseJuly 11, 2025 | reuters.comTeacher Retirement System of Texas Decreases Stake in Natera, Inc. (NASDAQ:NTRA)July 10, 2025 | marketbeat.comBank of New York Mellon Corp Has $132.45 Million Stock Position in Natera, Inc. (NASDAQ:NTRA)July 9, 2025 | marketbeat.comLee Johnson Capital Management LLC Invests $3.68 Million in Natera, Inc. (NASDAQ:NTRA)July 8, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Catalysts Driving Plug Power’s Turnaround CaseBy Jeffrey Neal Johnson | July 18, 2025View 3 Catalysts Driving Plug Power’s Turnaround CaseRocket Lab: Latest Catalysts Bolster the Bull CaseBy Ryan Hasson | July 3, 2025View Rocket Lab: Latest Catalysts Bolster the Bull CaseSuper Micro Stock May Benefit as Cooling Demand Takes OffBy Gabriel Osorio-Mazilli | July 16, 2025View Super Micro Stock May Benefit as Cooling Demand Takes Off3 Blockchain Stocks to Profit in a Decentralized WorldBy Chris Markoch | June 24, 2025View 3 Blockchain Stocks to Profit in a Decentralized WorldAMFPF, LH, NTRA, and BMXMF Company DescriptionsAmplifon OTCMKTS:AMFPF$23.85 0.00 (0.00%) As of 07/18/2025Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. It also operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy. Amplifon S.p.A.bioMerieux OTCMKTS:BMXMF$142.45 0.00 (0.00%) As of 07/18/2025bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.Labcorp NYSE:LH$243.73 -3.51 (-1.42%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$243.18 -0.55 (-0.23%) As of 07/18/2025 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.Natera NASDAQ:NTRA$138.90 -4.48 (-3.12%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$139.12 +0.22 (+0.16%) As of 07/18/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
